Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations

L. J. Hernan, B. P. Fuhrman, M. C. Papo, D. M. Steinhorn, C. L. Leach, N. Salman, P. R. Paczan, B. Kahn

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Objective: To determine whether reducing FIO2 during perfluorocarbon- associated gas exchange would cause deterioration of hemodynamics, lung mechanics, or gas exchange in normal piglets. Design: A prospective, controlled animal trial. Setting: Experimental animal laboratory in a university setting. Subjects: Twelve normal, anesthetized piglets, 7 to 14 days old, and weighing 3.31 ± 0.75 kg. Interventions: After the induction of anesthesia, tracheostomy and catheterization, piglets were stabilized. They were mechanically ventilated with a tidal volume of 15 mL/kg, inspiratory time of 25%, positive end-expiratory pressure of 4 cm H2O, and a respiratory rate of 20 to 28 breaths/min to obtain a baseline PaCO2 between 34 and 45 torr (4.7 and 6.0 kPa). Each animal was studied during continuous positive- pressure breathing, and during perfluorocarbon-associated gas exchange. They were ventilated at an FIO2 of 1.0 for 15 mins. FIO2 was randomly varied among 0.75, 0.5, and 0.3 every 15 mins, then returned to 1.0. At each FIO2, measurements of gas exchange, lung mechanics, and hemodynamics were made. After continuous positive-pressure breathing, perfluorocarbon-associated gas exchange was instituted by replacing the gaseous functional residual capacity of the lungs with perfluorooctylbromide. Animals were then ventilated and measurements were taken. Measurements and Main Results: At each measurements of gas exchange (arterial blood gases and saturation), lung mechanics (mean airway pressure, static end-inspiratory pressure, and peak inspiratory pressure), and hemodynamics (heart rate, and mean arterial, right atrial, pulmonary artery occlusion, and pulmonary arterial pressures) were recorded. In six piglets, cardiac output was measured at each FIO2 by thermodilution. Cardiac index, indexed oxygen delivery and consumption, and indexed pulmonary vascular resistance were derived using standard formulas. Piglets were well saturated at all FIO2 settings during continuous positive-pressure breathing. However, during perfluorocarbon-associated gas exchange, arterial saturation decreased to 72% at an FIO2 of 0.3. Cardiac index and oxygen consumption were not affected by reducing FIO2 during perfluorocarbon- associated gas exchange, and were not significantly different than during continuous positive-pressure breathing. Oxygen delivery was reduced at an FIO2 of 0.3 during perfluorocarbon-associated gas exchange, but oxygen consumption remained in the flow independent portion of the curve despite arterial desaturation. Pulmonary arterial pressure was higher during perfluorocarbon-associated gas exchange than during continuous positive- pressure breathing. Pulmonary arterial pressure and indexed pulmonary vascular resistance were significantly higher during perfluorocarbon- associated gas exchange at an FIO2 of 0.3 than at any other FIO2 settings. Conclusions: Piglets showed no adverse effects on lung mechanics during perfluorocarbon-associated gas exchange. Hemodynamics were well supported at all FIO2 settings, and arterial blood was fully oxygenated during perfluorocarbon-associated gas exchange at an FIO2 of ≥0.5.

Original languageEnglish (US)
Pages (from-to)553-559
Number of pages7
JournalCritical Care Medicine
Volume23
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Fluorocarbons
Gases
Oxygen
Pressure
Lung
Respiration
Mechanics
Hemodynamics
Oxygen Consumption
Arterial Pressure
Vascular Resistance
Functional Residual Capacity
Thermodilution
Positive-Pressure Respiration
Tracheostomy
Tidal Volume
Laboratory Animals
Respiratory Rate
Catheterization
Cardiac Output

Keywords

  • cardiac output
  • critical illness
  • hemodynamics
  • liquid ventilation
  • lung mechanics
  • lungs
  • mechanical ventilation
  • perflubron
  • perfluorocarbon
  • pulmonary gas exchange
  • respiratory failure

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Hernan, L. J., Fuhrman, B. P., Papo, M. C., Steinhorn, D. M., Leach, C. L., Salman, N., ... Kahn, B. (1995). Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations. Critical Care Medicine, 23(3), 553-559. https://doi.org/10.1097/00003246-199503000-00022

Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations. / Hernan, L. J.; Fuhrman, B. P.; Papo, M. C.; Steinhorn, D. M.; Leach, C. L.; Salman, N.; Paczan, P. R.; Kahn, B.

In: Critical Care Medicine, Vol. 23, No. 3, 1995, p. 553-559.

Research output: Contribution to journalArticle

Hernan, LJ, Fuhrman, BP, Papo, MC, Steinhorn, DM, Leach, CL, Salman, N, Paczan, PR & Kahn, B 1995, 'Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations', Critical Care Medicine, vol. 23, no. 3, pp. 553-559. https://doi.org/10.1097/00003246-199503000-00022
Hernan, L. J. ; Fuhrman, B. P. ; Papo, M. C. ; Steinhorn, D. M. ; Leach, C. L. ; Salman, N. ; Paczan, P. R. ; Kahn, B. / Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations. In: Critical Care Medicine. 1995 ; Vol. 23, No. 3. pp. 553-559.
@article{d52e8765a3dc449ca709f43694ec82ef,
title = "Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations",
abstract = "Objective: To determine whether reducing FIO2 during perfluorocarbon- associated gas exchange would cause deterioration of hemodynamics, lung mechanics, or gas exchange in normal piglets. Design: A prospective, controlled animal trial. Setting: Experimental animal laboratory in a university setting. Subjects: Twelve normal, anesthetized piglets, 7 to 14 days old, and weighing 3.31 ± 0.75 kg. Interventions: After the induction of anesthesia, tracheostomy and catheterization, piglets were stabilized. They were mechanically ventilated with a tidal volume of 15 mL/kg, inspiratory time of 25{\%}, positive end-expiratory pressure of 4 cm H2O, and a respiratory rate of 20 to 28 breaths/min to obtain a baseline PaCO2 between 34 and 45 torr (4.7 and 6.0 kPa). Each animal was studied during continuous positive- pressure breathing, and during perfluorocarbon-associated gas exchange. They were ventilated at an FIO2 of 1.0 for 15 mins. FIO2 was randomly varied among 0.75, 0.5, and 0.3 every 15 mins, then returned to 1.0. At each FIO2, measurements of gas exchange, lung mechanics, and hemodynamics were made. After continuous positive-pressure breathing, perfluorocarbon-associated gas exchange was instituted by replacing the gaseous functional residual capacity of the lungs with perfluorooctylbromide. Animals were then ventilated and measurements were taken. Measurements and Main Results: At each measurements of gas exchange (arterial blood gases and saturation), lung mechanics (mean airway pressure, static end-inspiratory pressure, and peak inspiratory pressure), and hemodynamics (heart rate, and mean arterial, right atrial, pulmonary artery occlusion, and pulmonary arterial pressures) were recorded. In six piglets, cardiac output was measured at each FIO2 by thermodilution. Cardiac index, indexed oxygen delivery and consumption, and indexed pulmonary vascular resistance were derived using standard formulas. Piglets were well saturated at all FIO2 settings during continuous positive-pressure breathing. However, during perfluorocarbon-associated gas exchange, arterial saturation decreased to 72{\%} at an FIO2 of 0.3. Cardiac index and oxygen consumption were not affected by reducing FIO2 during perfluorocarbon- associated gas exchange, and were not significantly different than during continuous positive-pressure breathing. Oxygen delivery was reduced at an FIO2 of 0.3 during perfluorocarbon-associated gas exchange, but oxygen consumption remained in the flow independent portion of the curve despite arterial desaturation. Pulmonary arterial pressure was higher during perfluorocarbon-associated gas exchange than during continuous positive- pressure breathing. Pulmonary arterial pressure and indexed pulmonary vascular resistance were significantly higher during perfluorocarbon- associated gas exchange at an FIO2 of 0.3 than at any other FIO2 settings. Conclusions: Piglets showed no adverse effects on lung mechanics during perfluorocarbon-associated gas exchange. Hemodynamics were well supported at all FIO2 settings, and arterial blood was fully oxygenated during perfluorocarbon-associated gas exchange at an FIO2 of ≥0.5.",
keywords = "cardiac output, critical illness, hemodynamics, liquid ventilation, lung mechanics, lungs, mechanical ventilation, perflubron, perfluorocarbon, pulmonary gas exchange, respiratory failure",
author = "Hernan, {L. J.} and Fuhrman, {B. P.} and Papo, {M. C.} and Steinhorn, {D. M.} and Leach, {C. L.} and N. Salman and Paczan, {P. R.} and B. Kahn",
year = "1995",
doi = "10.1097/00003246-199503000-00022",
language = "English (US)",
volume = "23",
pages = "553--559",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Cardiorespiratory effects of perfluorocarbon-associated gas exchange at reduced oxygen concentrations

AU - Hernan, L. J.

AU - Fuhrman, B. P.

AU - Papo, M. C.

AU - Steinhorn, D. M.

AU - Leach, C. L.

AU - Salman, N.

AU - Paczan, P. R.

AU - Kahn, B.

PY - 1995

Y1 - 1995

N2 - Objective: To determine whether reducing FIO2 during perfluorocarbon- associated gas exchange would cause deterioration of hemodynamics, lung mechanics, or gas exchange in normal piglets. Design: A prospective, controlled animal trial. Setting: Experimental animal laboratory in a university setting. Subjects: Twelve normal, anesthetized piglets, 7 to 14 days old, and weighing 3.31 ± 0.75 kg. Interventions: After the induction of anesthesia, tracheostomy and catheterization, piglets were stabilized. They were mechanically ventilated with a tidal volume of 15 mL/kg, inspiratory time of 25%, positive end-expiratory pressure of 4 cm H2O, and a respiratory rate of 20 to 28 breaths/min to obtain a baseline PaCO2 between 34 and 45 torr (4.7 and 6.0 kPa). Each animal was studied during continuous positive- pressure breathing, and during perfluorocarbon-associated gas exchange. They were ventilated at an FIO2 of 1.0 for 15 mins. FIO2 was randomly varied among 0.75, 0.5, and 0.3 every 15 mins, then returned to 1.0. At each FIO2, measurements of gas exchange, lung mechanics, and hemodynamics were made. After continuous positive-pressure breathing, perfluorocarbon-associated gas exchange was instituted by replacing the gaseous functional residual capacity of the lungs with perfluorooctylbromide. Animals were then ventilated and measurements were taken. Measurements and Main Results: At each measurements of gas exchange (arterial blood gases and saturation), lung mechanics (mean airway pressure, static end-inspiratory pressure, and peak inspiratory pressure), and hemodynamics (heart rate, and mean arterial, right atrial, pulmonary artery occlusion, and pulmonary arterial pressures) were recorded. In six piglets, cardiac output was measured at each FIO2 by thermodilution. Cardiac index, indexed oxygen delivery and consumption, and indexed pulmonary vascular resistance were derived using standard formulas. Piglets were well saturated at all FIO2 settings during continuous positive-pressure breathing. However, during perfluorocarbon-associated gas exchange, arterial saturation decreased to 72% at an FIO2 of 0.3. Cardiac index and oxygen consumption were not affected by reducing FIO2 during perfluorocarbon- associated gas exchange, and were not significantly different than during continuous positive-pressure breathing. Oxygen delivery was reduced at an FIO2 of 0.3 during perfluorocarbon-associated gas exchange, but oxygen consumption remained in the flow independent portion of the curve despite arterial desaturation. Pulmonary arterial pressure was higher during perfluorocarbon-associated gas exchange than during continuous positive- pressure breathing. Pulmonary arterial pressure and indexed pulmonary vascular resistance were significantly higher during perfluorocarbon- associated gas exchange at an FIO2 of 0.3 than at any other FIO2 settings. Conclusions: Piglets showed no adverse effects on lung mechanics during perfluorocarbon-associated gas exchange. Hemodynamics were well supported at all FIO2 settings, and arterial blood was fully oxygenated during perfluorocarbon-associated gas exchange at an FIO2 of ≥0.5.

AB - Objective: To determine whether reducing FIO2 during perfluorocarbon- associated gas exchange would cause deterioration of hemodynamics, lung mechanics, or gas exchange in normal piglets. Design: A prospective, controlled animal trial. Setting: Experimental animal laboratory in a university setting. Subjects: Twelve normal, anesthetized piglets, 7 to 14 days old, and weighing 3.31 ± 0.75 kg. Interventions: After the induction of anesthesia, tracheostomy and catheterization, piglets were stabilized. They were mechanically ventilated with a tidal volume of 15 mL/kg, inspiratory time of 25%, positive end-expiratory pressure of 4 cm H2O, and a respiratory rate of 20 to 28 breaths/min to obtain a baseline PaCO2 between 34 and 45 torr (4.7 and 6.0 kPa). Each animal was studied during continuous positive- pressure breathing, and during perfluorocarbon-associated gas exchange. They were ventilated at an FIO2 of 1.0 for 15 mins. FIO2 was randomly varied among 0.75, 0.5, and 0.3 every 15 mins, then returned to 1.0. At each FIO2, measurements of gas exchange, lung mechanics, and hemodynamics were made. After continuous positive-pressure breathing, perfluorocarbon-associated gas exchange was instituted by replacing the gaseous functional residual capacity of the lungs with perfluorooctylbromide. Animals were then ventilated and measurements were taken. Measurements and Main Results: At each measurements of gas exchange (arterial blood gases and saturation), lung mechanics (mean airway pressure, static end-inspiratory pressure, and peak inspiratory pressure), and hemodynamics (heart rate, and mean arterial, right atrial, pulmonary artery occlusion, and pulmonary arterial pressures) were recorded. In six piglets, cardiac output was measured at each FIO2 by thermodilution. Cardiac index, indexed oxygen delivery and consumption, and indexed pulmonary vascular resistance were derived using standard formulas. Piglets were well saturated at all FIO2 settings during continuous positive-pressure breathing. However, during perfluorocarbon-associated gas exchange, arterial saturation decreased to 72% at an FIO2 of 0.3. Cardiac index and oxygen consumption were not affected by reducing FIO2 during perfluorocarbon- associated gas exchange, and were not significantly different than during continuous positive-pressure breathing. Oxygen delivery was reduced at an FIO2 of 0.3 during perfluorocarbon-associated gas exchange, but oxygen consumption remained in the flow independent portion of the curve despite arterial desaturation. Pulmonary arterial pressure was higher during perfluorocarbon-associated gas exchange than during continuous positive- pressure breathing. Pulmonary arterial pressure and indexed pulmonary vascular resistance were significantly higher during perfluorocarbon- associated gas exchange at an FIO2 of 0.3 than at any other FIO2 settings. Conclusions: Piglets showed no adverse effects on lung mechanics during perfluorocarbon-associated gas exchange. Hemodynamics were well supported at all FIO2 settings, and arterial blood was fully oxygenated during perfluorocarbon-associated gas exchange at an FIO2 of ≥0.5.

KW - cardiac output

KW - critical illness

KW - hemodynamics

KW - liquid ventilation

KW - lung mechanics

KW - lungs

KW - mechanical ventilation

KW - perflubron

KW - perfluorocarbon

KW - pulmonary gas exchange

KW - respiratory failure

UR - http://www.scopus.com/inward/record.url?scp=0028958215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028958215&partnerID=8YFLogxK

U2 - 10.1097/00003246-199503000-00022

DO - 10.1097/00003246-199503000-00022

M3 - Article

C2 - 7874909

AN - SCOPUS:0028958215

VL - 23

SP - 553

EP - 559

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 3

ER -